p21Cip1 and p27Kip1 act in synergy to alter the sensitivity of naive T cells to TGF-β-mediated G1 arrest through modulation of IL-2 responsiveness

Journal of Immunology

Volumn 173, Issue 5, 2004, Pages 3093-3102

  Wolfraim, Lawrence A ^a,b   Walz, Thomas M ^a   James, Zakiya ^a   Fernandez, Tania ^a   Letterio, John J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b TolerGenics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIGEN; AUTOANTIGEN; BACTERIAL ANTIGEN; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD38 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD45RA ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2 RECEPTOR; PARASITE ANTIGEN; UNCLASSIFIED DRUG; CDK4 PROTEIN, MOUSE; CDKN1A PROTEIN, MOUSE; CDKN1B PROTEIN, MOUSE; CDKN2B PROTEIN, MOUSE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYCLINE; INTERLEUKIN 2; ONCOPROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN;

ALLERGY; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL LABELING; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MEMORY CELL; NEWBORN; NEWBORN PERIOD; PRENATAL EXPOSURE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UMBILICAL CORD BLOOD; ANIMAL; CELL CYCLE G1 PHASE; CYTOLOGY; DOWN REGULATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOID TISSUE; METABOLISM; MOUSE; MOUSE MUTANT; PHYSIOLOGY; UPREGULATION;

ANIMALS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; DOWN-REGULATION; G1 PHASE; IMMUNOLOGIC MEMORY; INTERLEUKIN-2; LYMPHOID TISSUE; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 4344622055     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.5.3093     Document Type: Article

References (27)

1. Kip2 during mouse development. Anat. Embryol. (Berl) 203:77.
2. Kip1-deficient cells. Curr. Biol. 9:163.
3. Mohapatra, S., and W. J. Pledger. 2001. Interdependence of cdk2 activation and interleukin-2Rα accumulation in T cells. J. Biol. Chem. 276:21984.
4. Kip1 regulates T cell proliferation. J. Biol. Chem. 276:21976.
5. Kip1-deficient mice. Cell 85:733.
6. Kip1. Cell 85:721.
7. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707.
8. Suzuki, A., Y. Tsutomi, N. Yamamoto, T. Shibutani, and K. Akahane. 1999. Mitochondrial regulation of cell death: mitochondria are essential for procaspase 3-p21 complex formation to resist Fas-mediated cell death. Mol. Cell. Biol. 19:3842.
9. Balomenos, D., J. Martin-Caballero, M. I. Garcia, I. Prieto, J. M. Flores, M. Serrano, and A. Martinez. 2000. The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development. Nat. Med. 6:171.
10. WAF1-dependent re-localization of cyclin/cdk complexes to the nucleus. Oncogene 21:8114.
11. Cip1/WAF-1, which promotes apoptosis. J. Immunol. 164:4032.
12. WAF-1/CIP-1 promotes apoptosis of activated/memory T cells and inhibits spontaneous systemic autoimmunity. J. Exp. Med. 199:547.
13. 1 checkpoint control. Cell 82:675.
14. Appleman, L. J., A. Berezovskaya, I. Grass, and V. A. Boussiotis. 2000. CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression. J. Immunol. 164:144.
15. Kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. J. Immunol. 168:2729.
16. INK4c cell cycle inhibitors in proliferation and tumorigenesis. EMBO J. 19:3496.
17. Rane, S. G., S. C. Cosenza, R. V. Mettus, and E. P. Reddy. 2002. Germ line transmission of the Cdk4 (R24C) mutation facilitates tumorigenesis and escape from cellular senescence. Mol. Cell. Biol. 22:644.
18. + Th1/Th2 T cells. Eur. J. Immunol. 30:2101.
19. Nelson, B. H., and D. M. Willerford. 1998. Biology of the interleukin-2 receptor. Adv. Immunol. 70:1.
20. Leonard, W. J., M. Kronke, N. J. Peffer, J. M. Depper, and W. C. Greene. 1985. Interleukin 2 receptor gene expression in normal human T lymphocytes. Proc. Natl. Acad. Sci. USA 82:6281.
21. Chastagner, P., J. L. Moreau, Y. Jacques, T. Tanaka, M. Miyasaka, M. Kondo, K. Sugamura, and J. Theze. 1996. Lack of intermediate-affinity interleukin-2 receptor in mice leads to dependence on interleukin-2 receptor α, β and γ chain expression for T cell growth. Eur. J. Immunol. 26:201.
22. Datto, M. B., J. P. Frederick, L. Pan, A. J. Borton, Y. Zhuang, and X. F. Wang. 1999. Targeted disruption of Smad3 reveals an essential role in transforming growth factor β-mediated signal transduction. Mol. Cell. Biol. 19:2495.
23. Yang, X., J. J. Letterio, R. J. Lechleider, L. Chen, R. Hayman, H. Gu, A. B. Roberts, and C. Deng. 1999. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β. EMBO J. 18:1280.
24. + T cells. Int. Immunopharmacol. 3:233.
25. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570.
26. Kehrl, J. H., L. M. Wakefield, A. B. Roberts, S. Jakowlew, M. varez-Mon, R. Derynck, M. B. Spom, and A. S. Fauci. 1986. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1037.
27. Ewen, M. E., H. K. Sluss, L. L. Whitehouse, and D. M. Livingston. 1993. TGF β inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74:1009.